Discover

ABT
Abbott Laboratories
102.61
200 x undefined
300 x undefined
bid
ask
+
0.38
0.37%
250 @ 04:01 AM
102.96 +0.35 (0.34%)
Ytd-18.10%
1y-23.75%
101.50
day range
103.19
81.97
52 week range
137.49
Open101.83Prev Close102.23Low101.50High103.19Mkt Cap178.73B
Vol27.05MAvg Vol10.33MEPS3.09P/E33.21Forward P/E16.91
Beta0.59Short Ratio2.83Inst. Own81.82%Dividend2.52Div Yield2.47
Ex Div Date10-15Earning10-1450-d Avg106.02200-d Avg105.201yr Est120.26

ABT News

3 Dividend Stocks to Buy and Hold for 10 Years
fool.com
3 Dividend Stocks to Buy and Hold for 10 Years

They have a knack for increasing their dividends even when facing challenges.

The Dividend Kings Ranked By Quality Scores (September 2026)
seekingalpha.com
The Dividend Kings Ranked By Quality Scores (September 2026)

Dividend Kings have a 50+ year track record of increasing dividends, showcasing resilience through e

Why Wall Street Is Becoming Even More Bullish About This Dividend King
fool.com
Why Wall Street Is Becoming Even More Bullish About This Dividend King

Wall Street analysts have raised price targets on Abbott, citing accelerating growth in its Medical

Abbott declares 411th consecutive quarterly dividend
prnewswire.com
Abbott declares 411th consecutive quarterly dividend

ABBOTT PARK, Ill., Sept. 17, 2026 /PRNewswire/ -- The board of directors of Abbott (NYSE: ABT) today

Is Abbott (ABT) a Buy as Wall Street Analysts Look Optimistic?
zacks.com
Is Abbott (ABT) a Buy as Wall Street Analysts Look Optimistic?

The recommendations of Wall Street analysts are often relied on by investors when deciding whether t

Is AbbVie the Best Dividend King to Buy in September?
fool.com
Is AbbVie the Best Dividend King to Buy in September?

It is certainly a good Dividend King to buy in September.

Bank of America Corp DE Acquires Shares of 17,672,543 Abbott Laboratories $ABT
defenseworld.net
Bank of America Corp DE Acquires Shares of 17,672,543 Abbott Laboratories $ABT

Bank of America Corp DE purchased a new stake in Abbott Laboratories (NYSE: ABT) during the second q

Billionaire Ken Griffin Just Loaded Up on This Dividend King, and Wall Street Still Sees Upside
fool.com
Billionaire Ken Griffin Just Loaded Up on This Dividend King, and Wall Street Still Sees Upside

Citadel, Ken Griffin's hedge fund, materially increased its stake in AbbVie; here's why you may want

Abbott (ABT) Rises As Market Takes a Dip: Key Facts
zacks.com
Abbott (ABT) Rises As Market Takes a Dip: Key Facts

Abbott (ABT) closed the most recent trading day at $103.09, moving +1.12% from the previous trading

Abbott to pay $384 mln over contaminated infant formula allegations, US Justice Dept says
reuters.com
Abbott to pay $384 mln over contaminated infant formula allegations, US Justice Dept says

Abbott Laboratories ​has ‌agreed to ​pay ​more than $384 million ⁠to ​settle ​allegations related to

Abbott reaches agreement with Department of Justice to resolve claims relating to 2022 infant formula recall
prnewswire.com
Abbott reaches agreement with Department of Justice to resolve claims relating to 2022 infant formul

Settlement does not represent any finding of fault or liability As the government has previously ind

benzinga.com
TD Cowen Reiterates Buy on Abbott Laboratories, Maintains $135 Price Target

TD Cowen analyst Joshua Jennings reiterates Abbott Laboratories (NYSE:ABT) with a Buy and maintai

benzinga.com
FDA Approves Abbott’s TactiFlex Duo Ablation Catheter, Sensor Enabled To Treat Patients With Challen

Abbott's TactiFlex™ Duo Ablation Catheter, Sensor Enabled™ combines pulsed field ablation (PFA)

FDA Approves Abbott's First Wearable Device for Dual Ketone and Glucose Tracking
benzinga.com
FDA Approves Abbott's First Wearable Device for Dual Ketone and Glucose Tracking

The FDA authorized Abbott's Libre Duo 10 Day, the first wearable tracking both glucose and keton

benzinga.com
FDA Authorizes Abbott's Libre Duo, First Device To Continuously Monitor Both Glucose And Ketones

The U.S. Food and Drug Administration today authorized the Libre Duo 10 Day Continuous Dual Glucose

10 Health Care Stocks Whale Activity In Today’s Session
benzinga.com
10 Health Care Stocks Whale Activity In Today’s Session

This whale alert can help traders discover the next big trading opportunities. Whales are entities w

Abbott Bypasses Appeals Process To Settle Ongoing Premature Infant Formula Litigation
benzinga.com
Abbott Bypasses Appeals Process To Settle Ongoing Premature Infant Formula Litigation

Abbott agreed to pay $670 million to resolve the Gill lawsuit and 2,000 other NEC claims involving i

note.com
Time can be an enemy that destroys your life, or an ally that grows your assets and increases your i

Last time, we looked at how dividends grow over 10, 20, and 30 years when 1 million yen is invested

es.investing.com
Neinor Homes (HOME)

¿En qué bolsa de valores cotiza Neinor Homes acc.? Las acciones de Neinor Homes cotizan y se negocia

finance.yahoo.com
Is Tandem Diabetes Care (TNDM) Undervalued As Investors Weigh Its 34% One Year Return?

Tandem Diabetes Care (TNDM) is back in focus after recent share price swings, with the stock closing

Abbott Laboratories stock gains on USD 385 million infant formula settlement and solid July earnings
ad-hoc-news.de
Abbott Laboratories stock gains on USD 385 million infant formula settlement and solid July earnings

Abbott Laboratories stock traded at USD 102.35 on September 19, 2026, after a nearly USD 385 million

Abbott Laboratories stock heads into the open after a 2.0 percent drop.
ad-hoc-news.de
Abbott Laboratories stock heads into the open after a 2.0 percent drop.

Abbott Laboratories stock closed at USD 101.88 on the NYSE on September 18, 2026, down 2.0 percent.